Rising incidences of such skin infections are expected to drive the market growth during the forecast period. For instance, according to the Journal of American Academy of Dermatology (JAAD) 2020, the prevalence of Prurigo nodularis ranges from 36.7 to 43.9 per 100,000 population in the U.S.
The global prurigo nodularis therapeutics market is estimated to be valued at US$ 824.4 million in 2021 and is expected to exhibit a CAGR of 4.2% over the forecast period (2021-2028).
Increasing drug approvals are expected to drive the market growth over the forecast period.
Figure 1. Global Prurigo Nodularis Therapeutics Market Share (%) in Terms of Value, By Region, 2021
Figure 2. Global Prurigo Nodularis Therapeutics Market Share (%), by Product Type, 2021
Prurigo Nodularis Therapeutics Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients